Reports Q2 revenue $116.6M, consensus $105.43M. Graham Purdy, President and CEO, commented, “Our consolidated second quarter results were better than expected. Modern Oral sales were $30.1M, increasing by 35% versus prior quarter and up 651% against the prior year. Stoker’s MST and looseleaf showed modest gains with Zig-Zag flat sequentially.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TPB:
- Avis Budget downgraded, Sprouts upgraded: Wall Street’s top analyst calls
- Turning Point Brands initiated with a Hold at Needham
- Turning Point Brands: Promising Growth in Nicotine Pouches and Diverse Revenue Streams, But Current Valuation Justifies Hold Rating
- FRE Nicotine Pouches partners with PBR for ‘Unleash The Beast’